Becton, Dickinson and Co. | BDX

Stock Price
243.64
Daily Change
3.46 1.44%
Monthly
6.77%
Yearly
2.99%
Q1 Forecast
236.11



Peers Price Chg Day Year Date
Terumo 3,030.00 19.00 0.63% -39.38% Jan/24
Agilent 151.48 -0.85 -0.56% 16.72% Jan/24
Abbott 125.17 2.00 1.62% 11.31% Jan/24
Align Technology 233.21 -1.85 -0.79% -9.28% Jan/24
Avanos Medical 15.81 0.01 0.06% -19.50% Jan/24
Baxter International 32.43 -0.02 -0.06% -14.39% Jan/24
Becton, Dickinson and Co. 243.64 3.46 1.44% 2.99% Jan/24
Bio-Rad Laboratories 355.88 1.85 0.52% 12.42% Jan/24
Boston Scientific 101.99 0.34 0.33% 67.66% Jan/24
Cooper Companies 97.54 1.88 1.97% 2.89% Jan/24
Danaher 245.82 0.12 0.05% 8.11% Jan/24
Dexcom 88.78 1.00 1.13% -29.82% Jan/24
Edwards Lifesciences 68.96 0.02 0.03% -6.24% Jan/24
Exact Sciences 55.98 0.85 1.54% -12.89% Jan/24
Globus Medical 92.84 0.42 0.45% 72.76% Jan/24
Hologic 71.02 0.32 0.45% -4.21% Jan/24
Integra LifeSciences 26.05 0.45 1.76% -37.66% Jan/24
Intuitive Surgical 584.01 -24.02 -3.95% 57.81% Jan/24
J&J 146.94 0.39 0.27% -7.56% Jan/24
Masimo 170.24 2.16 1.29% 36.93% Jan/24
Medtronic 90.12 0.85 0.95% 5.05% Jan/24
Patterson Companies 30.93 0.03 0.10% 1.94% Jan/24
Insulet 280.35 3.15 1.14% 41.11% Jan/24
Solventum Corp 74.99 1.39 1.89% -0.01% Jan/24
Stryker 394.19 0.56 0.14% 26.38% Jan/24
Teleflex 181.00 0.35 0.19% -25.19% Jan/24
Thermo Fisher Scientific 575.25 0.46 0.08% 6.88% Jan/24
Tandem Diabetes Care 36.50 1.01 2.85% 58.76% Jan/24
Dentsply International 19.52 0.07 0.36% -44.32% Jan/24
Zimmer Biomet Holdings 110.87 1.15 1.05% -8.01% Jan/23

Indexes Price Day Year Date
US500 6101 -17.46 -0.29% 24.66% Jan/24

Becton, Dickinson and Co. traded at $243.64 this Friday January 24th, increasing $3.46 or 1.44 percent since the previous trading session. Looking back, over the last four weeks, Becton, Dickinson and Co. gained 6.77 percent. Over the last 12 months, its price rose by 2.99 percent. Looking ahead, we forecast Becton, Dickinson and Co. to be priced at 236.11 by the end of this quarter and at 230.56 in one year, according to Trading Economics global macro models projections and analysts expectations.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.